You just read:

Takeda Presents Analyses From Vedolizumab Data in Ulcerative Colitis at 2016 Digestive Disease Week (DDW) Annual Meeting

News provided by

Takeda Pharmaceutical Company Limited

May 23, 2016, 12:33 ET